Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

NCT02633501 is registered in ClinicalTrials.gov with Guerbet as lead sponsor.

NCT NCT02633501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02633501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Lead sponsor
Guerbet
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2016
Completion date
January 31, 2018
Enrollment
312 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

blood brain barrier defect, cns lesion